Modular Medical, Inc. (MODD)
Healthcare · NCM
Fundamentals
Valuation and ratings
Modular Medical, Inc. trades at USD2.37, which is 17% below the USD2.78 our discounted cash flow model puts on the business. On that measure alone it screens as undervalued, though a DCF is an argument rather than a measurement, and the market is frequently right about why something is cheap.
Our moat model scores it 10 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
About Modular Medical, Inc.
Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It also offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. Modular Medical, Inc. is headquartered in San Diego, California.
MODD passes 2 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Common questions
Is Modular Medical, Inc. (MODD) undervalued?
Against our discounted cash flow estimate of USD2.78, MODD at USD2.37 is 17% below fair value. That is one model's answer, not a recommendation, and most of a DCF's output sits in a terminal value nobody can forecast.
The full research page for MODD, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.